Racial Disparities in Intravenous Recombinant Tissue Plasminogen Activator Use Persist at Primary Stroke Centers.
Academic Article
- Overview
- Research
- Identity
- Additional document info
- View All
Overview
publication date
- October 14, 2015
has subject area
- Administration, Intravenous
- Adolescent
- Adult
- Aged
- Black or African American
- Chi-Square Distribution
- Databases, Factual
- Female
- Fibrinolytic Agents
- Health Policy
- Health Services Accessibility
- Healthcare Disparities
- Hispanic or Latino
- Humans
- Male
- Middle Aged
- Multivariate Analysis
- Odds Ratio
- Recombinant Proteins
- Retrospective Studies
- Risk Factors
- Socioeconomic Factors
- Stroke
- Thrombolytic Therapy
- Tissue Plasminogen Activator
- Treatment Outcome
- United States
- White People
- Young Adult
published in
- J Am Heart Assoc Journal
- Journal of the American Heart Association Journal